Pfizer to Sell Georgia Manufacturing Plant to Xethanol

May 25, 2006
Patricia Van Arnum

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

ePT--the Electronic Newsletter of Pharmaceutical Technology

Xethanol Corporation's (New York, NY) subsidiary CoastalXethanol signed a letter of intent with Pfizer Inc. (New York, NY) to purchase Pfizer's pharmaceutical manufacturing complex in Augusta, Georgia.

Xethanol Corporation's (New York, NY, www.xethanol.com) subsidiary CoastalXethanolsigned a letter of intent with Pfizer Inc. (New York, NY, www.pfizer.com) topurchase Pfizer's pharmaceutical manufacturing complex in Augusta,Georgia.

The 40-acre site includes an 89,100-ft2 manufacturingfacility, a25,000-ft2 warehouse facility, 7300-ft2 oflaboratory space, and 16,000-ft2 of offices and conference rooms. CoastalXethanol intends to retrofit the site to produce 35 million gallons per year of ethanol.

The facility will produce ethanol from cellulosic and other biomasswaste streams generated by industrial producers in the surroundingareas. CoastalXethanol may produce biodiesel in this facility underXethanol's sublicense from H2Diesel, Inc.  

Related Content:

PharmTech News | Manufacturing